Tebuconazole TC, SC, WDG, EC, EW

Above 500 g/kg ± 25 g/kg

.3 IMPURITIES

Not relevant.

.4 PHYSICAL PROPERTIES

.4.1 pH range (MT 75, CIPAC F, p.205)

pH range: 7.0 to 9.5

.4.2 Wet sieve test (MT 59.3, CIPAC F, p.179)

Maximum: 2 % retained on a 75 μm test sieve

.4.3 Suspensibility (MT 15.1, CIPAC F, p.45) (Notes 1 and 2)

A minimum of 60 % of the tebuconazole content found under .2.2 shall be in

suspension after 30 min in CIPAC Standard Water D at 30 °C ± 2°C (Notes 3

and 4). Alternatively, if the buyer requires other CIPAC Standard Waters or

time to be used, then this shall be specified when ordering.

.4.4 Persistent foam (MT 47.1, CIPAC F, p.152) (Note 5)

Maximum: 20 mL after 1 min. at 30°C ± 2°C. (Note 3)

.4.5 Wettability (MT 53.3.1, CIPAC F, p.165)

The product shall be completely wetted in 1 min. without swirling.

.5 STORAGE STABILITY

.5.1 Stability at 54 °C (MT 46.1.1, CIPAC F, p.149) (Note 6)

After storage at 54 ± 2 °C for 14 days, the determined average active

ingredient content must not be lower than 97 % relative to the determined

average content found before storage and the product shall continue to comply

with .4.1, .4.2. 4.3. and .4.5

TEBUCONAZOLE AQUEOUS SUSPENSION CONCENTRATES

FAO Specification 494/SC/S/F/ (2000)

.2 ACTIVE INGREDIENT

.2.1 Identity tests (494/WP/M/2, CIPAC H, p.267)

An identity test is required if the identity of the active ingredient is in doubt.

.2.2 Tebuconazole ( 494/SC/M/3, CIPAC H, p.267)

The tebuconazole content shall be declared (g/kg or g/L at 20 °C ± 2°C) (Note

2) and, when determined, the content obtained shall not differ from that

declared content by more than the following amounts:

Declared content Permitted tolerance

Above 250 up to 500g/kg or g/L ± 5 % of the declared content

Above 500 g/kg or g/L ± 25 g/kg

3 IMPURITIES

Not relevant.

.4 PHYSICAL PROPERTIES

.4.1 Mass per millilitre at 20 °C (MT 3.3, CIPAC F, p.18)

If required, the range of the mass per millilitre (g/mL) shall be declared.

.4.2 pH range (MT 75, CIPAC F, p.205)

pH range: 8.0 to 10.0

.4.3 Pourability (MT 148, CIPAC F, p.348) (Note 3)

Maximum "rinsed residue": 0.5 %

.4.4 Spontaneity of dispersion (MT 160, CIPAC F, p.391) (Note 4)

A minimum of 60 % of the tebuconazole content found under .2.2 shall be in

suspension after 5 min in CIPAC Standard Water D at 30 °C ± 2°C (Notes 5

and 6). Alternatively, if the buyer requires other CIPAC Standard Waters to be

used, then this shall be specified when ordering.

.4.5 Suspensibility (MT 161, CIPAC F, p.394) (Note 4)

A minimum of 90 % of the tebuconazole content found under .2.2 shall be in

suspension after 30 min in CIPAC Standard Water D at 30 °C ± 2°C (Notes 5,

6 and 7). Alternatively, if the buyer requires other CIPAC Standard Waters to

be used, then this shall be specified when ordering.

.4.6 Wet sieve test (MT 59.3, CIPAC F, p.179)

Maximum: 1 % of the product shall be retained on a 75 mm test sieve.

4.7 Persistent foam (MT 47.2, CIPAC F, p.152) (Note 8)

Maximum: 40 mL after 1 min at 30°C ± 2°C (Note 6)

.5 STORAGE STABILITY

.5.1 Stability at 0 °C (MT 39, CIPAC F, p.128)

After storage at 0 ± 2 °C for 7 days, the product shall continue to comply with

.4.4, .4.5 and .4.6.

5.2 Stability at 54 °C (MT 46.1, CIPAC F, p.149) (Note 9)

After storage at 54 ± 2 °C for 14 days (Note 6), the determined average active

ingredient content must not be lower than 97 % relative to the determined

average found before storage and the product shall conti-nue to comply with

.4.2, .4.3, .4.4, .4.5 and .4.6.

TEBUCONAZOLE WATER DISPERSIBLE GRANULES

FAO Specification 494/WG/S/F (2000)

.2 ACTIVE INGREDIENT

.2.1 Identity tests ( 494/WG/M/2, CIPAC H, p.266)

An identity test is required if the identity of the active ingredient is in doubt.

2.2 Tebuconazole (494/WG/M/3, CIPAC H, p.266)

The tebuconazole content shall be declared (g/kg) and, when determined, the

content obtained shall not differ from that declared by more than the following

amounts:

Declared content Permitted tolerance

Above 250 up to 500 g/kg ± 5 % of the declared content

Above 500 g/kg ± 25 g/kg

.3 IMPURITIES

.3.1 Water (MT 30, CIPAC F, p.91)

Maximum: 25 g/kg

.4 PHYSICAL PROPERTIES

.4.1 pH range (MT 75, CIPAC F, p.205)

pH range: 6.0 to 9.0

.4.2 Wettability (MT 53.3, CIPAC F, p.165)

It shall be completely wetted in 1 min without swirling.

.4.3 Wet sieve test (MT 167, CIPAC F, p.416)

Maximum: 1.0 % retained on a 75 mm test sieve

.4.4 Suspensibility (MT 168, CIPAC F, p.417) (Notes 1, 2)

A minimum of 60 % of the tebuconazole content found under .2.2 shall be in

suspension after 30 min in CIPAC Standard Water D at 30 °C ± 2°C (Note 3).

Alternatively, if the buyer requires other CIPAC Standard Waters to be used,

then this shall be specified when ordering.

.4.5 Persistent foam (MT 47, CIPAC F, p.152) (Note 4)

Maximum: 10 mL after 1 min at 30°C ± 2°C (Note 3)

.4.6 Dustiness (MT 171, CIPAC F, p.425) (Note 5)

Maximum: 30 mg collected dust

.4.7 Flowability (MT 172, CIPAC F, p.430)

At least 95 % of the product shall pass through a 5 mm test sieve after 20

drops on the sieve.

.5 STORAGE STABILITY

.5.1 Stability at 54 °C (MT 46.1.1, CIPAC F, p.149) (Note 6)

After storage at 54 ± 2 °C for 14 days (Note 3), the determined average active

ingredient content must not be lower than 97 % relative to the determined

average content found before storage and the product shall continue to comply

with .4.1, .4.3, .4.4 and .4.7.

TEBUCONAZOLE EMULSION OIL IN WATER

FAO Specification 494/EW/S/F (2000)

.2 ACTIVE INGREDIENT

.2.1 Identity tests (494/EW/M/2, CIPAC H, p.267)

An identity test is required if the identity of the active ingredient is in doubt.

2.2 Tebuconazole (494/EW/M/3, CIPAC H, p.267)

The tebuconazole content shall be declared (g/kg or g/L at 20 °C) (Note 2)

and, when determined, the content obtained shall not differ from that declared

by more than the following amounts:

Declared content Permitted tolerance

Above 100 up to 250 g/kg ± 6 % of the declared content

Above 250 up to 500 g/kg ± 5 % of the declared content

.3 IMPURITIES

Not relevant.

.4 PHYSICAL PROPERTIES

.4.1 Mass per millilitre at 20 °C (MT 3.3, CIPAC F, p.18)

If required, the mass per millilitre (g/L) at 20 °C shall be declared.

.4.2 pH range (MT 75, CIPAC F, p.205)

pH range: 6.0 to 9.0

.4.3 Pourability (MT 148, CIPAC F, p.348)

"Rinsed residue": maximum 0.5 %

.4.4 Wet sieve test (MT 167, CIPAC F, p.416)

Maximum: 0.5 % retained on a 75 mm test sieve.

.4.5 Emulsion stability and re-emulsification (MT 36.1.1, CIPAC F, p.108)

After the heat stability test (.5.2), the product, when diluted at 30 °C ± 2°C

(Note 3) with CIPAC Standard Waters A and D, shall comply with the following:

Time after dilution                Limits of stability

0 h                                   Initial emulsification complete

0.5 h                                "Cream", maximum: 0 mL

2.0 h                                "Cream", maximum: 1 mL

"Free oil", maximum: 0 mL

24 h (Note 4)                  Re-emulsification complete

24.5 h (Note 4)                "Cream", maximum: 0 mL

"Free oil", maximum: 0 mL

In special cases, a test using CIPAC Standard Waters A and D before the

heat stability test may be necessary. Alternatively, if the buyer requires other

CIPAC Standard Waters to be used, than this shall be specified when

ordering.

.4.6 Persistent foam (MT 47, CIPAC F, p.152) (Note 5)

Maximum: 25 mL after 1 min.

4.7 Flash point (MT 12.2, CIPAC F, p.37) (Note 6)

If required, the flash point of the product shall not be lower than the minimum

declared flash point. A closed cup method shall be used and the method

stated.

.5 STORAGE STABILITY

.5.1 Stability at 0 °C (MT 39.1, CIPAC F, p.128)

After storage at 0 ± 2 °C for 7 days, the product shall comply with .4.4. No

separation (Note 7) of oily matter shall be visible after gentle agitation.

.5.2 Stability at 54 °C (MT 46.1.3, CIPAC I, to be published) (Note 8)

After storage at 54 ± 2°C for 14 days (Note 3), the determined average active

ingredient content must not be lower than 97 % relative to the determined

average content before storage and the product shall continue to comply with

.4.3, .4.4 and, if relevant, .4.2.